Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feng Chai

Showing results (201-210 of 215) with videos related to

Pageof 22
Sort By:
Journal of Food and Drug Analysis|March 24, 2018
Comprehensive two-dimensional APTES-decorated MCF7-cell membrane chromatographic system for characterizing potential anti-breast-cancer components from Yuanhu-Baizhi herbal medicine pairXiao-Yu Wang, Xuan Ding, Yong-Fang Yuan, et al.
Annals of Internal Medicine|November 3, 2005
Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donorBarna D Tugwell, Priti R Patel, Ian T Williams, et al.
Molecules (Basel, Switzerland)|March 17, 2019
Phenolic Compounds from <i>Humulus lupulus</i> as Natural Antimicrobial Products: New Weapons in the Fight against Methicillin Resistant <i>Staphylococcus aureus</i>, <i>Leishmania mexicana</i> and <i>Trypanosoma brucei</i> StrainsLaetitia Bocquet, Sevser Sahpaz, Natacha Bonneau, et al.
European Journal of Pharmacology|January 9, 2026
The efficacy of proprotein convertase subtilisin/kexin 9 inhibitors for coronary atherosclerotic plaque burden and phenotype: A meta-analysis and trial sequential analysisBo-Feng Chai, Qian-Bei He, Zhi-Xiang Yu, et al.
Journal of Biomedical Materials Research. Part A|February 3, 2016
Layer-by-layer coating of textile with two oppositely charged cyclodextrin polyelectrolytes for extended drug deliveryJatupol Junthip, Nicolas Tabary, Feng Chai, et al.
ACS Applied Materials & Interfaces|May 21, 2015
Bioinspired Titanium Drug Eluting Platforms Based on a Poly-β-cyclodextrin-Chitosan Layer-by-Layer Self-Assembly Targeting InfectionsAlexandra Pérez-Anes, Myriem Gargouri, William Laure, et al.
Cancer|May 19, 2012
Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors: results of a multicenter phase 2 trialAndrew J Wagner, John M Goldberg, Steven G Dubois, et al.
Hepatology (Baltimore, Md.)|March 27, 2014
Bioactive compound reveals a novel function for ribosomal protein S5 in hepatic stellate cell activation and hepatic fibrosisWei-Heng Xu, Hong-Gang Hu, Yuan Tian, et al.
Investigational New Drugs|October 9, 2014
Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumorsIgor Puzanov, Jeffrey Sosman, Armando Santoro, et al.
Cancer Discovery|November 6, 2023
First-in-Human Study of the Reversible BTK Inhibitor Nemtabrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia and B-Cell Non-Hodgkin LymphomaJennifer A Woyach, Deborah M Stephens, Ian W Flinn, et al.
Pageof 22

Showing results (201-210 of 215) with videos related to

Sort By:
Pageof 22
Journal of Food and Drug Analysis|March 24, 2018
Comprehensive two-dimensional APTES-decorated MCF7-cell membrane chromatographic system for characterizing potential anti-breast-cancer components from Yuanhu-Baizhi herbal medicine pairXiao-Yu Wang, Xuan Ding, Yong-Fang Yuan, et al.
Annals of Internal Medicine|November 3, 2005
Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donorBarna D Tugwell, Priti R Patel, Ian T Williams, et al.
Molecules (Basel, Switzerland)|March 17, 2019
Phenolic Compounds from <i>Humulus lupulus</i> as Natural Antimicrobial Products: New Weapons in the Fight against Methicillin Resistant <i>Staphylococcus aureus</i>, <i>Leishmania mexicana</i> and <i>Trypanosoma brucei</i> StrainsLaetitia Bocquet, Sevser Sahpaz, Natacha Bonneau, et al.
European Journal of Pharmacology|January 9, 2026
The efficacy of proprotein convertase subtilisin/kexin 9 inhibitors for coronary atherosclerotic plaque burden and phenotype: A meta-analysis and trial sequential analysisBo-Feng Chai, Qian-Bei He, Zhi-Xiang Yu, et al.
Journal of Biomedical Materials Research. Part A|February 3, 2016
Layer-by-layer coating of textile with two oppositely charged cyclodextrin polyelectrolytes for extended drug deliveryJatupol Junthip, Nicolas Tabary, Feng Chai, et al.
ACS Applied Materials & Interfaces|May 21, 2015
Bioinspired Titanium Drug Eluting Platforms Based on a Poly-β-cyclodextrin-Chitosan Layer-by-Layer Self-Assembly Targeting InfectionsAlexandra Pérez-Anes, Myriem Gargouri, William Laure, et al.
Cancer|May 19, 2012
Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors: results of a multicenter phase 2 trialAndrew J Wagner, John M Goldberg, Steven G Dubois, et al.
Hepatology (Baltimore, Md.)|March 27, 2014
Bioactive compound reveals a novel function for ribosomal protein S5 in hepatic stellate cell activation and hepatic fibrosisWei-Heng Xu, Hong-Gang Hu, Yuan Tian, et al.
Investigational New Drugs|October 9, 2014
Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumorsIgor Puzanov, Jeffrey Sosman, Armando Santoro, et al.
Cancer Discovery|November 6, 2023
First-in-Human Study of the Reversible BTK Inhibitor Nemtabrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia and B-Cell Non-Hodgkin LymphomaJennifer A Woyach, Deborah M Stephens, Ian W Flinn, et al.
Pageof 22